Kaare Harald Bønaa

Author information from the last article

Hjertemedisinsk avdeling

St. Olavs hospital, Universitetssykehuset i Trondheim

Norsk hjerteinfarktregister

Seksjon for medisinske kvalitetsregistre

St. Olavs hospital, Universitetssykehuset i Trondheim

Fakultet for medisin og helsevitenskap

Institutt for sirkulasjon og bildediagnostikk

NTNU

Forfatterbidrag: idé, utforming/design, datainnsamling, tolking av data, revisjon av manus og godkjenning av innsendt manus.

Kaare Harald Bønaa er dr.med., spesialist i indremedisin og i hjertesykdommer, overlege i invasiv kardiologi ved Klinikk for hjertemedisin, St. Olavs hospital, Trondheim, faglig leder av Norsk hjerteinfarktregister og professor emeritus ved NTNU.

Articles by Kaare Harald Bønaa

Correction: Incidence and case fatality of acute myocardial infarction in Norway 2013–2021

Kaare Harald Bønaa,
Kari Krizak Halle,
Ragna Elise Støre Govatsmark,
Veronica Bendiktsen Berge,
Ida Almenning Kiel,
Gerhard Sulo,
Rune Kvåle

24.10.2024: Tidsskr Nor Legeforen 2024; 144. doi: 10.4045/tidsskr.24.0237 The paragraph above Table 1 should say: The number of patients with a first-time infarction event decreased from 14 361 (391/100 000) in 2013 to 11 264 (271/100 000) in 2021, (…) Table 1 should say: All myocardial infarctions in 2021: n...

Incidence and case fatality of acute myocardial infarction in Norway 2013–2021

Kaare Harald Bønaa,
Kari Krizak Halle,
Ragna Elise Støre Govatsmark,
Veronica Bendiktsen Berge,
Ida Almenning Kiel,
Gerhard Sulo,
Rune Kvåle

10.10.2024: Over the past 100 years, ischemic heart disease mortality has changed considerably in Norway. In the first half of the last century, mortality steadily increased, except for a marked decrease during World War II (1). Mortality then rose substantially in the post-war years, peaking in the 1970s, and...

Does a history of cardiovascular disease or cancer affect mortality after SARS-CoV-2 infection?

Rune Kvåle,
Kaare Harald Bønaa,
Rachel Forster,
Kirsten Gravningen,
Pétur Benedikt Júlíusson,
Tor Åge Myklebust

29.12.2020: Cardiovascular disease and cancer have been described as possible risk factors for serious illness and death as a result of COVID-19 (1, 2). In addition to comorbidities, previously published studies have shown that increasing age and male sex are also associated with a greater mortality risk (3–6)...

Treatment of ST-elevation myocardial infarction – an observational study

Julie Synnøve Arnesen,
Knut Henrik Strøm,
Kaare Harald Bønaa,
Rune Wiseth

18.11.2019: In myocardial infarction with ST-segment elevation, rapid reperfusion of the occluded coronary artery is important to reduce myocardial damage. The benefit of reperfusion therapy is greatest when it is administered within 2–3 hours of symptom onset (1, 2). In Norway, the European Society of...

Coronary angiography in non-ST-elevation acute myocardial infarction – whom and when?

Kaare Harald Bønaa,
Terje Steigen

13.11.2017: Many patients with non-ST-elevation acute myocardial infarction (NSTEMI) ultimately undergo percutaneous coronary intervention or coronary artery bypass surgery. Both procedures require prior diagnostic coronary angiography. Should all patients with NSTEMI be referred for coronary angiography? And...

Coronary heart disease mortality

Kaare Harald Bønaa

04.03.2011: Prevention and treatment have led to a reduction in coronary heart disease mortality. However, this has levelled off and there may be an increase for women in the future. So there is no reason to rest on our laurels. During the last 70 years Norway has seen dramatic changes in mortality from...